Manulife (Manufacturers Life Insurance)
RIGL icon

Manulife (Manufacturers Life Insurance)’s Rigel Pharmaceuticals RIGL Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-5,183
Closed -$222K – 2899
2025
Q4 		$222K Buy
+5,183
New +$195K ﹤0.01% 2478
2024
Q2 		– Sell
-6,789
Closed -$100K – 3036
2024
Q1 		$100K Hold
6,789
– – ﹤0.01% 2769
2023
Q4 		$98.4K Sell
6,789
-178
-3% -$1.82K ﹤0.01% 2824
2023
Q3 		$75.2K Hold
6,967
– – ﹤0.01% 2883
2023
Q2 		$89.9K Sell
6,967
-183
-3% -$2.47K ﹤0.01% 2878
2023
Q1 		$94.4K Hold
7,150
– – ﹤0.01% 2757
2022
Q4 		$107K Sell
7,150
-386
-5% -$3.54K ﹤0.01% 2786
2022
Q3 		$88.9K Sell
7,536
-6
-0.1% -$81 ﹤0.01% 2840
2022
Q2 		$85.2K Hold
7,542
– – ﹤0.01% 2958
2022
Q1 		$225K Sell
7,542
-2,076
-22% -$56.2K ﹤0.01% 2691
2021
Q4 		$255 Buy
9,618
+158
+2% +$4.77K ﹤0.01% 2734
2021
Q3 		$343K Sell
9,460
-683
-7% -$26.9K ﹤0.01% 2567
2021
Q2 		$440K Buy
10,143
+54
+0.5% +$2.04K ﹤0.01% 2528
2021
Q1 		$345K Sell
10,089
-464
-4% -$18.4K ﹤0.01% 2522
2020
Q4 		$369K Buy
10,553
+280
+3% +$8.11K ﹤0.01% 2393
2020
Q3 		$247K Sell
10,273
-405
-4% -$9.94K ﹤0.01% 2433
2020
Q2 		$192K Sell
10,678
-375
-3% -$6.75K ﹤0.01% 2528
2020
Q1 		$172K Buy
11,053
+596
+6% +$12.7K ﹤0.01% 2384
2019
Q4 		$224K Sell
10,457
-673
-6% -$13.9K ﹤0.01% 2514
2019
Q3 		$204K Hold
11,130
– – ﹤0.01% 2576
2019
Q2 		$290K Sell
11,130
-260
-2% -$5.87K ﹤0.01% 2384
2019
Q1 		$293K Sell
11,390
-632
-5% -$14.4K ﹤0.01% 2280
2018
Q4 		$276K Buy
12,022
+515
+4% +$14.5K ﹤0.01% 2193
2018
Q3 		$370K Sell
11,507
-1,407
-11% -$42.2K ﹤0.01% 2451
2018
Q2 		$366K Buy
12,914
+1,661
+15% +$59.1K ﹤0.01% 2633
2018
Q1 		$398K Sell
11,253
-277
-2% -$11.1K ﹤0.01% 2486
2017
Q4 		$447K Buy
11,530
+1,373
+14% +$52.3K ﹤0.01% 2392
2017
Q3 		$258K Buy
10,157
+255
+3% +$6.2K ﹤0.01% 2776
2017
Q2 		$270K Buy
9,902
+1,383
+16% +$37.9K ﹤0.01% 2766
2017
Q1 		$282K Buy
8,519
+1,369
+19% +$34.9K ﹤0.01% 2594
2016
Q4 		$170K Buy
7,150
+279
+4% +$7.99K ﹤0.01% 2914
2016
Q3 		$252K Sell
6,871
-353
-5% -$10.1K ﹤0.01% 2596
2016
Q2 		$161K Buy
7,224
+842
+13% +$20.9K ﹤0.01% 2891
2016
Q1 		$131K Buy
6,382
+154
+2% +$3.8K ﹤0.01% 2900
2015
Q4 		$188 Buy
6,228
+224
+4% +$6.79K ﹤0.01% 2709
2015
Q3 		$149 Buy
6,004
+136
+2% +$4.06K ﹤0.01% 2897
2015
Q2 		$189 Sell
5,868
-406
-6% -$15.5K ﹤0.01% 2900
2015
Q1 		$224 Buy
6,274
+73
+1% +$2K ﹤0.01% 2650
2014
Q4 		$141 Buy
6,201
+312
+5% +$6.31K ﹤0.01% 2891
2014
Q3 		$115 Buy
5,889
+22
+0.4% +$621 ﹤0.01% 3029
2014
Q2 		$212K Sell
5,867
-1,005
-15% -$34.2K ﹤0.01% 2673
2014
Q1 		$266 Buy
6,872
+25
+0.4% +$891 ﹤0.01% 2519
2013
Q4 		$195 Sell
6,847
-108
-2% -$3.17K ﹤0.01% 2741
2013
Q3 		$249 Sell
6,955
-25
-0.4% -$912 ﹤0.01% 2488
2013
Q2 		$233K Buy
+6,980
New +$316K ﹤0.01% 2448

Other funds holding RIGL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s RIGL Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) sold out of Rigel Pharmaceuticals (RIGL) in Q1 2026, closing a stake of 5,183 shares — an estimated $222K sold.

Manulife (Manufacturers Life Insurance) first reported a position in RIGL in Q2 2013 and held it in 45 quarters. The position peaked at $447K in Q4 2017. 159 funds tracked by Wall St. Rank hold RIGL as of Q1 2026.

  • Manulife (Manufacturers Life Insurance) reported no remaining Rigel Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 5,183 Rigel Pharmaceuticals shares in Q1 2026, an estimated $222K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Rigel Pharmaceuticals in Q2 2013 and held it in 45 quarters.
  • Manulife (Manufacturers Life Insurance)'s Rigel Pharmaceuticals position peaked at $447K in Q4 2017.
  • 159 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.